Barry W. Siegel - Concepedia

Concepedia

Author

Barry W. Siegel

Scripps Research Institute

Also Known As

B Siegel, B W Siegel, B. W. Siegel, Barry W Siegel, Barry W. Siegel, Siegel, Barry W.

24

Publications

2.1K

Citations

17

H-Index

38

Concepts

All Affiliations

Scripps Research Institute The Ohio State University at Marion University of Utah Union Institute & University Vanderbilt University

BW

About

Barry W. Siegel is an author at Scripps Research Institute specializing in medicine, pharmacology, and biochemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	1.3K
2	Biochemistry	6	6	287
3	Natural Sciences	1	1	94
4	Biology	1	1	150
5	Cellular Physiology	1	1	150

Barry W. Siegel

×

18

Publications

2.1K

Citations

17

H-Index

	Year	Citations
A novel adenylyl cyclase-activating serotonin receptor (5-HT7) implicated in the regulation of mammalian circadian rhythms Timothy W. Lovenberg, Bruce M. Baron, Luı́s de Lecea, Neuron SleepAlertnessMedicinePhysiologyPharmacology	1993	690
Preclinical characterization of the potential of the putative atypical antipsychotic MDL 100,907 as a potent 5-HT2A antagonist with a favorable CNS safety profile. John H. Kehne, B M Baron, A A Carr, Journal of Pharmacology and Experimental Therapeutics	1996	358
Two members of a distinct subfamily of 5-hydroxytryptamine receptors differentially expressed in rat brain. MG Erlander, Timothy W. Lovenberg, B M Baron, Proceedings of the National Academy of Sciences	1993	182
Cilia Regeneration in the Sea Urchin Embryo: Evidence for a Pool of Ciliary Proteins Walter Auclair, Barry W. Siegel Science GeneticsLate GastrulaeCytoskeletonCellular PhysiologyEmbryology	1966	150
Rapid down regulation of β-adrenoceptors by co-administration of desipramine and fluoxetine Bruce M. Baron, Ann-Marie Ogden, Barry W. Siegel, European Journal of Pharmacology Molecular PharmacologyMedicinePhysiologyNeuroendocrine MechanismExperimental Pharmacology	1988	114
Molecular cloning and functional expression of 5-HT1E-like rat and human 5-hydroxytryptamine receptor genes. Timothy W. Lovenberg, MG Erlander, B M Baron, Proceedings of the National Academy of Sciences Molecular BiologyMolecular PharmacologyMr77 GeneMolecular NeuroscienceMolecular Physiology	1993	94
Characterization of the novel 5-HT3 antagonists MDL 73147EF (dolasetron mesilate) and MDL 74156 in NG108-15 neuroblastoma × glioma cells Peter H. Boeijinga, M. Galvan, B M Baron, European Journal of Pharmacology Molecular PharmacologyMedicineNovel 5-Ht3 AntagonistsAnti-cancer AgentHigh-grade Gliomas	1992	68
[3H]5,7-Dichlorokynurenic acid, a novel radioligand labels NMDA receptor-associated glycine binding sites Bruce M. Baron, Barry W. Siegel, A L Slone, European Journal of Pharmacology Molecular Pharmacology BiochemistryFunctional SelectivityMedicineG Protein-coupled ReceptorReceptor (Biochemistry)	1991	68
[3H]MDL 105,519, a high-affinity radioligand for the N-methyl-D-aspartate receptor-associated glycine recognition site. B M Baron, Barry W. Siegel, B.L. Harrison, Journal of Pharmacology and Experimental Therapeutics	1996	57
Pharmacological characterization of MDL 105,519, an NMDA receptor glycine site antagonist Bruce M. Baron, Boyd L. Harrison, John H. Kehne, European Journal of Pharmacology Molecular PharmacologyPharmacological CharacterizationBiochemistryFunctional SelectivityMedicine	1997	48

Page 1